Pyxis Oncology is trading 5.07% down at $1.91 on October 8, 2026; no clear driver is established. - No company announcement dated October 7 or 8 appeared in the release listing; the latest listed release was the October 2 offering close. - The offering included 36,047,919 shares or pre-funded warrants, plus warrants for another 49,310,352 shares. - Higher Treasury yields and Middle East supply concerns lifted oil and pressured markets; supplied index moves do not establish a clear stock driver.